The reasoning layer for evidence-based decisions
Rare disease foundations · Biotech
Method
Every consequential decision is a search: many possible paths, most of them dead ends, one worth committing to. We make that search explicit, exhaustive, and auditable.
Assemble the evidence
Literature, registries, natural history studies, trial results — unified into a single structured evidence base, so every path you consider starts from everything that is known.
Explore every path
Competing strategies are expanded into decision trees and traversed systematically — each possibility followed through to its consequences, each weak branch pruned with a reason attached.
Commit with confidence
What survives is a recommendation with its full reasoning trail: the evidence it rests on, the alternatives it beat, and the assumptions that would change the answer.
Who it's for
Which research to fund next
Rare disease foundations steward scarce capital against urgent timelines. We help boards weigh therapeutic avenues, natural history gaps, and platform bets on the evidence — not on whoever presented last.
Which program to advance
Portfolio, indication, and trial-design choices carry consequences that compound for years. We map the branch points ahead of you and keep the reasoning behind each call ready for diligence.
About
Decisions you can defend.
Traversal.bio sits between the evidence and the decision. We combine structured evidence synthesis with systematic exploration of the decision space, so that foundations and biotech teams can see every path they didn't take — and exactly why the one they chose won.